Formerra, a leader in performance materials distribution, announced the implementation of a transportation surcharge to address continued cost escalation across…
Browsing: HealthCare
On March 25, 2026, Hengrui Pharma (600276.SH; 01276.HK) announced robust financial results for the full year 2025, fueled by its…
Wellgistics Health, Inc. (Wellgistics or the Company) (NASDAQ:WGRX) today announced that it has entered into a non-exclusive, non-binding Letter of…
– Multiple Regulatory Approvals and Strategic Collaborations Strengthened Market Position Key Results Highlights: – Revenue Growth: 8.6% increase to approximately HK$1,813.8…
Everest Medicines today announced that it has entered into an Asset Purchase Agreement with Corxel Pharmaceuticals Hong Kong Limited (CORXEL).…
Pacific Avenue Capital Partners (Pacific Avenue), a Los Angeles-headquartered private equity firm focused on corporate carve-outs and other complex transactions…
March 9, Everest Medicines (HKG: 1952) announced the commercial launch of VELSIPITY(R) (etrasimod arginine tablets) in Mainland China, highlighted by…
International Women’s Day: Why Menopause May Be a Missed Cardiovascular Risk Window As International Women’s Day prompts renewed focus on…
Formerra, LLC (Formerra), a leading distributor of engineered thermoplastic resins, additives, elastomers, and other specialty materials, today announced the appointment…
– First glucokinase-activator (GKA) approval outside mainland China – Approval supports a differentiated approach to Type 2 diabetes (T2D) management…
– Exhibition space fully secured prior to the show, reflecting strong exhibitor confidence in Northern Vietnam’s laboratory and scientific markets…
CanSino Biologics Inc. (688185.SH/06185.HK) announced that the Company has obtained the Notification of Approval of Supplemental Drug Application issued by…
Bioxytran, Inc. (OTCQB: BIXT), a clinical-stage biotechnology company developing breakthrough antiviral treatments, today announced it has initiated a research collaboration…
12 February 2026, Modern Dental Group Limited (Modern Dental or the Group, HKG: 3600), a leading global dental prosthetic device provider,…
Bioxytran, Inc. (OTCQB: BIXT) today announced positive clinical results from its recently completed Phase 2 randomized, double-blind, placebo-controlled, dose-optimization trial…
Essex Bio-Technology Limited (EssexBio or the Company; HKG: 1061) today announces its successful participation in the 41st Asia-Pacific Academy of…
According to disclosure of interests filed with the Hong Kong Stock Exchange (HKEX), the Government of Singapore Investment Corporation (GIC)…
According to the disclosure of interests information released by the Hong Kong Stock Exchange, on 5 February, GIC Private Limited…
On February 6, Distinct Healthcare Holdings Limited (Distinct Healthcare or the Company, Stock Code: 2677.HK), a leading player in China’s…
Everest Medicines today announced that China’s National Medical Products Administration (NMPA) has approved VELSIPITY(R) (etrasimod arginine tablets) for the treatment…